Trial Location Pending โ�� Prospera ZEDE, Roatรกn, Honduras

Post-Vaccination Syndrome Clinical Trial

Investigating metabolic modulation therapy for persistent symptoms after COVID-19 vaccination. A 3-month randomized controlled trial with comprehensive testing at no cost.

✓ Free Participation ✓ Comprehensive Testing ✓ Expert Care Team

Check Your Eligibility → Explore the Science →

Get Started

Fill out this form and we'll contact you within 48 hours

First Name *

Last Name *

Email Address *

Phone Number *

Symptoms persist for 6+ months?

Can travel to Roatรกn, Honduras?

Your information is secure. Privacy Policy

Understanding Post-Vaccination Syndrome

Recent research has identified key mechanisms underlying PACVS, pointing toward metabolic dysfunction as a potential therapeutic target.

What is PACVS?

Post-Acute COVID-19 Vaccination Syndrome (PACVS) is a condition involving persistent, multi-system symptoms that develop after COVID-19 vaccination. With an estimated prevalence of approximately 0.02%, it shares features with post-viral syndromes such as ME/CFS and dysautonomia.

Research shows that over 80% of patients experience malaise and chronic fatigue as primary symptoms, with overlapping clusters affecting cognitive, cardiovascular, and nervous system function.

Common Symptoms

• Persistent fatigue
• Post-exertional malaise
• Cognitive impairment
• Exercise intolerance
• Dysautonomia
• Neuropathic pain
• Cardiovascular symptoms
• Sleep disturbances

⚡ Mitochondrial Dysfunction

Research identifies impaired mitochondrial function including reduced ATP production, oxidative stress, and elevated succinate levels indicating a block in Complex II of the energy pathway. This contributes to the fatigue and exercise intolerance characteristic of PACVS.

🔨 Spike Protein Persistence

Growing evidence suggests persistent spike protein, particularly the S1 subunit, contributes to endothelial dysfunction, inflammatory signaling, and metabolic shifts toward glycolysis, disrupting normal cellular energy production.

🔥 Metabolic Impairment

Studies show patients reach their lactate threshold earlier and burn fat less efficiently during physical activity. These metabolic changes correlate directly with symptom severity and reduced exercise tolerance.

Explore the full scientific research →

Who May Qualify

Review the criteria below to see if you may be eligible. Our team will conduct full screening during your consultation.

✓

Inclusion Criteria

✓ Symptoms began within 2 weeks of COVID-19 vaccination
✓ Symptoms persisting for 6+ months
✓ Significant fatigue not relieved by rest
✓ Post-exertional malaise (24+ hours)
✓ 50%+ reduction in pre-illness activities
✓ Cognitive impairment or orthostatic intolerance
✓ Able to travel to Roatรกn, Honduras

Exclusion Criteria

✕ Have not received a COVID-19 vaccine
✕ COVID-19 infection within 14 days post-vaccination
✕ Active SARS-CoV-2 infection
✕ Untreated hypothyroidism, anemia, or major depression
✕ Currently pregnant or breastfeeding

What to Expect

Your participation journey from application to study completion.

Submit Interest Form

Complete the form above with your contact information and basic screening questions. Our team will review and contact you within 48 hours.

Initial Consultation (Visit 1)

Visit our clinic in Prospera ZEDE, Roatรกn, Honduras for comprehensive baseline assessment including blood samples, quality of life surveys, 6-minute walking test, and heart rate variability measurement.

📍 Prospera ZEDE, Roatรกn, Honduras 🕐 ~2-3 hours

3-Month Intervention

Take your assigned supplement (ViTAL SCAN or placebo) daily at home. Track doses using our notification app. Continue normal activities while monitoring symptoms.

🏠 At home 📷 Daily tracking

Follow-Up Assessment (Visit 2)

Return for final measurements. We'll repeat all baseline tests to evaluate changes in metabolic markers, physical performance, and quality of life.

📍 Prospera ZEDE, Roatรกn, Honduras 🕐 ~2-3 hours

The ViTAL SCAN Intervention

A metabolic modulation approach targeting mitochondrial function and cellular energy production.

Study Intervention

Based on emerging research linking PACVS to mitochondrial dysfunction, the ViTAL SCAN protocol combines amino acids, vitamins, and metabolic modulators to support cellular energy generation, reduce oxidative stress, and regulate inflammatory pathways.

Product mockup — final product may differ in appearance.

L-Glutamine 13g

Creatine 6.3g

L-Citrulline 5.75g

L-Serine 4g

L-Arginine 3g

L-Carnitine 2g

Sarcosine 2g

Taurine 1.5g

NAC 1.2g

Vitamin C 0.5g

NMN 0.25g

What We Measure

♥

Quality of Life

PAC-19QoL questionnaire for functional independence

🏃

Physical Performance

6-Minute Walking Test for exercise capacity

💓

Heart Rate Variability

Continuous monitoring via chest strap

🧬

Metabolic Markers

HbA1c, blood lactate, lipid profile

🔥

Inflammatory Markers

C-reactive protein and spike protein levels

Common Questions

Is there any cost to participate? +

No, participation is completely free. The study protocol, supplements, and all tests are provided at no cost. You will need to arrange your own transportation to Roatรกn, Honduras for study visits.

Will I be compensated? +

Monetary compensation is not provided. The benefit to participants includes free comprehensive testing and potentially benefiting from the intervention if assigned to the treatment group.

Will I know which group I'm in? +

This is a double-blinded study. Neither you nor the clinical staff will know your group assignment during the trial. This ensures unbiased results. You may learn your assignment after the study concludes.

What are the potential risks? +

All ViTAL SCAN components have established safety profiles at doses below their lowest observed adverse effect levels. Potential side effects are generally mild and may include gastrointestinal discomfort. Full details will be provided in the informed consent form.

How many visits are required? +

Two in-person visits to our clinic in Prospera ZEDE, Roatรกn, Honduras: one for initial baseline assessment and one for follow-up after the 3-month intervention period.

Is my information kept confidential? +

Yes. All data is anonymized when shared with researchers. Your name, birthdate, and identifying information are removed and replaced with a unique identifier for analysis purposes only.

Has this study been ethically reviewed? +

Yes. This study is currently under consideration for IRB approval and is registered on ClinicalTrials.gov (NCT06967428).